We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Allergan Plc | LSE:0Y7T | London | Ordinary Share | IE00BY9D5467 | ALLERGAN ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 154.21 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDM0Y7T TIDMBARC
FORM 8.3 - Amendment to Purchase and Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC. Company dealt in ALLERGAN PLC Class of relevant security to which the ORD dealings being disclosed relate (Note 2) Date of dealing 08 May 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Class of relevant security: ORD Long Short Number (%) Number (%) (1) Relevant securities 4,322,884 1.31% 2,946,075 0.89% (2) Derivatives (other than options): 2,887,345 0.88% 2,368,331 0.72% (3) Options and agreements to purchase/sell: 180,100 0.05% 132,400 0.04% TOTAL: 7,390,329 2.24% 5,446,806 1.65%
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: Long Short Number (%) Number (%) (1) Relevant securities (2) Derivatives (other than options) (3) Options and agreements to purchase/sell Total
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit Purchase 7 192.3700 USD Purchase 15 192.7700 USD Purchase 35 192.1500 USD Purchase 66 192.5431 USD Purchase 77 193.0300 USD Purchase 100 192.6800 USD Purchase 100 192.5600 USD Purchase 116 192.1279 USD Purchase 200 192.9550 USD Purchase 200 192.2650 USD Purchase 300 192.7666 USD Purchase 300 192.8833 USD Purchase 354 192.2835 USD Purchase 400 192.2950 USD Purchase 500 192.4492 USD Purchase 583 192.0354 USD Purchase 600 192.7800 USD Purchase 700 192.2042 USD Purchase 800 192.8125 USD Purchase 800 192.5312 USD Purchase 950 192.1584 USD Purchase 1,552 192.0849 USD Purchase 1,600 192.1471 USD Purchase 1,679 192.1574 USD Purchase 1,907 192.2668 USD Purchase 2,105 192.7307 USD Purchase 2,455 193.0197 USD Purchase 3,268 192.2360 USD Purchase 4,682 192.1946 USD Purchase 4,828 192.7226 USD Purchase 5,142 192.6418 USD Purchase 5,312 192.6768 USD Purchase 5,523 192.1527 USD Purchase 6,198 192.2601 USD Purchase 6,597 192.7439 USD Purchase 6,909 192.1397 USD Purchase 7,555 192.1556 USD Purchase 9,804 192.1238 USD Purchase 12,400 192.1505 USD Purchase 16,288 192.6579 USD Purchase 24,208 192.4691 USD Purchase 28,865 192.7180 USD Purchase 49,000 192.4035 USD Purchase 75,000 192.4600 USD Purchase 82,742 192.7223 USD Purchase 95,229 192.6050 USD Purchase 138,224 192.3712 USD Purchase 285,258 192.6521 USD Purchase 403,031 192.2596 USD Purchase 517,871 192.1448 USD Purchase 555,298 193.0200 USD Purchase 895,338 192.2453 USD Sale 1 192.5000 USD Sale 4 192.5450 USD Sale 5 192.6780 USD Sale 5 192.3920 USD Sale 6 192.5333 USD Sale 7 192.3700 USD Sale 7 192.3742 USD Sale 8 192.7062 USD Sale 12 192.5250 USD Sale 16 191.9900 USD Sale 22 192.4600 USD Sale 87 192.4200 USD Sale 100 192.5700 USD Sale 100 192.7200 USD Sale 100 192.7900 USD Sale 100 193.0600 USD Sale 210 192.4252 USD Sale 233 192.8500 USD Sale 300 192.7933 USD Sale 315 192.5196 USD Sale 393 192.3847 USD Sale 415 192.4697 USD Sale 486 192.3797 USD Sale 529 192.5295 USD Sale 700 192.2042 USD Sale 1,349 192.5638 USD Sale 1,705 192.2549 USD Sale 2,191 192.3816 USD Sale 2,944 192.5787 USD Sale 3,139 192.5307 USD Sale 3,573 192.3849 USD Sale 3,907 192.3191 USD Sale 4,000 192.3777 USD Sale 4,500 192.5824 USD Sale 5,416 192.7088 USD Sale 6,162 192.6616 USD Sale 7,353 192.5806 USD Sale 7,668 192.3709 USD Sale 7,866 192.4044 USD Sale 8,500 192.0732 USD Sale 8,525 192.6476 USD Sale 9,708 192.5201 USD Sale 9,906 192.8178 USD Sale 11,114 192.6146 USD Sale 12,500 192.6852 USD Sale 12,841 192.3838 USD Sale 13,133 192.3719 USD Sale 13,361 192.3794 USD Sale 14,232 192.4958 USD Sale 18,628 192.5163 USD Sale 23,351 192.5123 USD Sale 24,171 192.6498 USD Sale 24,932 192.3445 USD Sale 26,042 192.4976 USD Sale 28,071 192.5626 USD Sale 32,408 192.3684 USD Sale 35,093 193.0200 USD Sale 39,953 192.8725 USD Sale 41,122 192.4989 USD Sale 54,075 192.3770 USD Sale 67,026 192.6917 USD Sale 77,455 192.4777 USD Sale 82,952 192.6070 USD Sale 95,915 192.4747 USD Sale 250,000 192.1500 USD Sale 375,571 192.2149 USD Sale 446,743 192.3340 USD Sale 267,871 192.1399 USD Sale 545,729 192.9328 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant Price per unit e.g. CFD (Note 6) securities (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option money name, selling, securities price e.g. date paid/received e.g. purchasing, to which American, per unit call varying the option European (Note 5) option etc. relates etc. (Note 7)
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5) e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction Details Price per unit (Note 8) (if applicable) (Note 5)
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 (Open Positions) attached? YES Date of disclosure: 12 May 2020 Contact name: Large Holdings Regulatory Operations Telephone number: 020 3134 7213 If a connected EFM, name of offeree/offeror with which connected If a connected EFM, state nature of connection
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name Written or Number of Exercise Type Expiry relevant purchased securities price date to which the option or derivative relates Call Options Purchased 600 175.0000 American Jan 15, 2021 Call Options Purchased 6,400 185.0000 American Jan 15, 2021 Put Options Written 200 190.0000 American Aug 21, 2020 Call Options Written -1,400 230.0000 American Jun 19, 2020 Call Options Written -1,500 220.0000 American Aug 21, 2020 Put Options Purchased -4,500 70.0000 American Jan 15, 2021 Put Options Written 8,200 150.0000 American May 15, 2020 Call Options Purchased 6,400 175.0000 American May 15, 2020 Put Options Written 43,900 105.0000 American Jan 15, 2021 Put Options Purchased -16,500 115.0000 American Jan 15, 2021 Call Options Written -42,500 165.0000 American Jan 21, 2022 Call Options Written -1,100 200.0000 American Aug 21, 2020 Put Options Purchased -1,200 65.0000 American Jan 15, 2021 Call Options Purchased 1,200 190.0000 American May 15, 2020 Call Options Purchased 500 165.0000 American Jan 15, 2021 Call Options Purchased 9,500 170.0000 American Jun 19, 2020 Call Options Purchased 32,500 175.0000 American Jan 21, 2022 Put Options Purchased -1,000 195.0000 American May 15, 2020 Put Options Purchased -5,100 170.0000 American Jan 15, 2021 Put Options Written 33,200 140.0000 American Jun 19, 2020 Call Options Purchased 1,700 170.0000 American May 15, 2020 Put Options Purchased -2,600 75.0000 American Jan 15, 2021 Put Options Purchased -900 175.0000 American Aug 21, 2020 Put Options Purchased -6,300 170.0000 American Jun 19, 2020 Put Options Written 6,700 140.0000 American Jan 15, 2021 Put Options Written 600 150.0000 American Jun 19, 2020 Call Options Purchased 4,400 190.0000 American Jan 15, 2021 Call Options Written -7,200 260.0000 American Jan 15, 2021 Put Options Purchased -29,400 150.0000 American Jan 15, 2021 Put Options Written 2,700 180.0000 American May 15, 2020 Put Options Written 100 165.0000 American May 15, 2020 Call Options Purchased 3,400 160.0000 American Jan 15, 2021 Put Options Purchased -900 185.0000 American Jan 15, 2021 Put Options Purchased -2,400 160.0000 American Jan 15, 2021 Put Options Written 3,700 215.0000 American Jan 15, 2021 Call Options Purchased 600 150.0000 American Jan 15, 2021 Put Options Purchased -600 185.0000 American May 15, 2020 Put Options Purchased -7,200 180.0000 American Jan 15, 2021 Put Options Written 4,500 195.0000 American Aug 21, 2020 Call Options Purchased 9,100 195.0000 American Jan 15, 2021 Put Options Purchased -100 195.0000 American Jun 19, 2020
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200512005721/en/
CONTACT:
BARCLAYS PLC
SOURCE: BARCLAYS PLC Copyright Business Wire 2020
(END) Dow Jones Newswires
May 12, 2020 12:10 ET (16:10 GMT)
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions